ARTIMMUNE
Artimmune is a research company that consults in preclinical research services in the fields of immunology and inflammation.
ARTIMMUNE
Social Links:
Industry:
Biotechnology Consulting Pharmaceutical Product Research
Founded:
2009-12-10
Address:
Orléans, Centre, France
Country:
France
Website Url:
http://www.artimmune.com
Total Employee:
1+
Status:
Active
Contact:
33 238694863
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta ReCAPTCHA ReCAPTCHA V2 COVID-19
Similar Organizations
Addax Biosciences
Addax Biosciences is a biotechnology research organization that focuses on developing alternatives for formalin.
AICROS
AICROS is an network of small to midsize CROs which provides clinical research services for the biotech and medical technology industries.
Ando
Ando specialises in biotech, pharma development, clinical trials, strategic planning, data analysis, and interim management solutions.
Preclinics
This company is a diverse research organization and service supplier. We are operating out of three facilities in Germany.
The Institute of Bioorganic Chemistry of the Polish Academy of Sciences
The Institute of Bioorganic Chemistry of the Polish Academy of Sciences is a research center that conducts research in various areas.
Trent Graduate Students' Association
Trent Graduate Students' Association is a research company that promotes equity and social justice by maintaining communication.
Vivonics Preclinical
Vivonics Preclinical is a research organization that specialize in assessing the effects of potential new medicines on vital organ systems.
Official Site Inspections
http://www.artimmune.com
- Host name: serveur15.processx.net
- IP address: 51.210.155.12
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Artimmune"
ABOUT US | Altimmune Website
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies.See details»
Artimmune - Crunchbase Company Profile & Funding
Artimmune is a research company that consults in preclinical research services in the fields of immunology and inflammation.See details»
Altimmune – Investors Overview
Jun 13, 2025 The Investor Relations website contains information about Altimmune's business for stockholders, potential investors, and financial analysts.See details»
Altimmune, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Altimmune is a biotech company based in Montgomery County, MD, that specializes in creating vaccines and biological products to address public health needs. The company utilizes a …See details»
ALTIMMUNE, INC._December 31, 2024 - SEC.gov
Dec 31, 2024 Altimmune, Inc. is a clinical stage biopharmaceutical company focused on developing treatments for obesity, metabolic and liver diseases. Our lead product candidate, …See details»
Altimmune (ALT) Company Profile & Description
Jul 7, 2025 Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor …See details»
Altimmune a clinical stage biopharmaceutical company
Altimmune a clinical stage biopharmaceutical company developing peptide-based therapeutics. Our focus is developing next generation peptide therapeutics for obesity and liver diseaseSee details»
Altimmune - The Org
Altimmune is a clinical stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment …See details»
Altimmune Appoints Life Sciences Industry Veteran Greg Weaver …
Nov 11, 2024 Mr. Weaver joins Altimmune with over 25 years of finance experience across a range of publicly-traded and privately-held life sciences companies. Most recently, he was …See details»
Who Owns Altimmune – CanvasBusinessModel.com
Dec 19, 2024 Ownership Structure of Altimmune Altimmune is a biopharmaceutical company focused on developing products to stimulate robust and durable immune responses for the …See details»
Altimmune - Crunchbase Company Profile & Funding
Altimmune is an emerging biotechnology company located in Montgomery County, MD. Altimmune develops vaccines and other biological products to address unmet market and public health needs.See details»
Altimmune Announces Initiation of RESTORE Phase 2 Trial
6 days ago Altimmune Announces Initiation of RESTORE Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol-Associated Liver Disease (ALD) July 09, 2025 07:30 ET | …See details»
Executive Team | Altimmune Website
Suite 201-S Gaithersburg, MD 20878 (240) 654-1450 ALTIMMUNE About Us Pipeline Clinical TrialsSee details»
Press Releases – Altimmune
May 8, 2025 The Investor Relations website contains information about Altimmune's business for stockholders, potential investors, and financial analysts.See details»
Altimmune Announces Initiation of RECLAIM Phase 2 Trial …
May 19, 2025 The primary endpoint of the trial is a change in alcohol consumption, assessed as the change from baseline in the average number of heavy drinking days per week at Week 24, …See details»
Board of Directors – Altimmune
Mr. Hodges was first elected to our board of directors in September 2003 and is currently serving as chair of our audit committee. He is Managing Partner of Redmont Capital, a private equity …See details»
Seasoned Biopharmaceutical Industry Executives Teri Lawver and …
Feb 25, 2025 “We are thrilled to welcome Teri and Jerry to our Board as we move into late-stage clinical development for pemvidutide and begin preparing for the transition to a pre-commercial …See details»
Altimmune Announces Initiation of RECLAIM Phase 2 Trial …
GAITHERSBURG, Md., May 19, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics …See details»
Mitchel Sayare, Ph.D. | Altimmune Website
Sayare also served as president of the 95%-owned ImmunoGen subsidiary, Apoptosis Technology, where he was responsible for managing operations for the organization.See details»
Greg Weaver, MBA | Altimmune Website
Greg Weaver, MBA Chief Financial Officer Mr. Weaver joined Altimmune as Chief Financial Officer in November 2024. He has over 25 years of finance experience across a range of …See details»